but is conditionally recommended for patients with hand OA. A single trial suggested analgesic efficacy of chondroitin sulfate, without evidence of harm, in hand OA. Hydroxychloroquine is strongly recommended against in patients with knee, hip, and/or hand OA. Well-designed RCTs of hydroxychloroquine, conducted in the subset of patients with erosive hand OA, have demonstrated no efficacy. Methotrexate is strongly recommended against in patients with knee, hip, and/or hand OA. Well-designed RCTs